| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.077 |
0.08 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.08 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.08 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.08 |
| mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.09 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.09 |
| mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |
| mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.09 |
| mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.09 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |